The Best Penny Stocks to Own Right Now - 185% Profit Potential

Every investor's dream is to find the next "big thing." Think Amazon.com Inc. (NASDAQ: AMZN) in the 1990s. Apple Inc. (NASDAQ: AAPL) before it unveiled the iPhone. Even Tesla Inc. (NASDAQ: TSLA) has rocketed 86% higher in 2020 alone.

But the big tech stocks aren't the only big winners.

If you're looking for that next breakout stock, you might want to consider buying a few penny stocks. They trade for under $5, and they can have an immense upside on just a few dollars' change in share price.

To find the best penny stocks to own, I typically incorporate several different strategies. I always want to make sure these companies are viable and provide a favorable risk-reward profile. I'll look at the company's balance sheet to examine cash flow and debt. Then I'll look for positive signals like insider buying among executives.

My top penny stocks to own this week pass one or more of these tests. The best one is even positioned for a 185% breakout in the next year.

Let's get started...

Best Penny Stock to Own This Week, No. 3: WisdomTree Investments

WisdomTree Investments Inc. (NYSE: WETF) is a popular provider of exchange-traded products. You've probably seen their exchange-traded funds (ETFs), exchange-traded notes, and exchange-traded commodities. The firm has about $60 billion under management, a figure that is small compared to its competitors. The firm competes with some of the biggest names in finance, including BlackRock Inc. (NYSE: BLK), Vanguard, and Invesco Ltd. (NYSE: IVZ).

Launched in 2006, it has grown to the seventh-largest provider of ETFs in the United States.

Our NEW Premium Stock Pick could double in the next 12 months. There’s still time to get in on the BIGGEST gains, if you act fast. Get it now for free.

WisdomTree currently trades around $5.15 thanks to a recent uptick from 52-week lows. The company is a prime takeover target for a larger ETF or asset manager. We see an upside for WETF at $6.50 by the end of the year. That would represent a potential upside of 26% from current prices.

This next penny stock, however, could more than double in the next 12 months - 136% growth...

Best Penny Stock to Own This Week, No. 2: Cerecor Inc.

Cerecor Inc. (NASDAQ: CERC) is a biopharmaceutical company that specializes in treatments for rare and orphan diseases and neurological conditions.

The stock has pulled back in recent months thanks to its purchase of Aevi Genomic Medicine. However, this deal is poised to be a major catalyst for Cerecor in the future. The combination of the two companies will address pediatric orphan diseases.

The company has a fantastic pipeline of new drugs, led by three therapies for inborn errors of metabolism. Specialization in these diseases makes Cerecor a potential takeover target by a larger pharmaceutical company in the future.

And its stakeholders have been very bullish on its future. Last week, one of the company's directors, Armistice, purchased $5 million in CERC stock, a sign that it expects a big windfall in the future. With shares trading at $3.80 per share, we agree. Our price target for CERC stock is $9 over the next 12 months.

That figure represents an upside of 136% by this time next year. But you won't get more upside than from our very best penny stock to buy today.

This next penny stock could deliver 185% for today's investor.

The Best Penny Stock to Own This Week

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

If you're looking for huge upside, look no further than the biotech industry.

ADMA Biologics Inc. (NASDAQ: ADMA) is a biotech firm that develops and commercializes human plasma and plasma-derived therapeutics. This means that the firm specializes in the treatment of patients with immunodeficiency disorders at risk for infection and others at risk for certain infectious diseases. It caters to immunity-compromised patients in the United States.

The company currently markets three FDA-approved plasma-derived biologics. And the upside for this niche market is significant - despite the recent downturn in the stock.

This week, we saw the company issue a large amount of stock through a new offering at $3.50 per share. The company is raising money for its ongoing push to bring products to market and continue its operations. It was positive to see its CEO, CFO, other executives, and large investors pour tens of millions of dollars back into the company. They're expecting a massive return for the effort.

ADMA stock trades right now at roughly $3.50 per share. But we see a track for the stock to trade at $10 per share in the next year. That price target represents a potential upside of 185% in the next 12 months.

Action to Take: Penny stocks can have a tendency to break out on even the smallest successes. So when you see a penny stock with healthy risk-reward, trusted by analysts, you're likely to get the highest gain by investing as soon as possible. In this case, ADMA Biologics Inc. (NASDAQ: ADMA) can earn 185% for today's investor.

You Can Collect Four Separate Paydays in Under a Minute with This Options Trading Secret

Live on camera, America's No. 1 Pattern Trader is showing you the secret behind some of his biggest trades to date.

Watch as he uses this special tool to collect four separate paydays in under a minute - all from enormous companies like Netflix, Apple, Facebook, even Amazon.

While it may have taken Tom years to invent this moneymaking "machine," it's super easy to understand and utilize.

All it takes is a few simple mouse clicks, and you could be hundreds, even thousands, richer.

This is an opportunity you won't want to miss out on.

Click here to get started today.

Follow Money Morning onFacebook and Twitter.

About the Author

Garrett Baldwin is a globally recognized research economist, financial writer, consultant, and political risk analyst with decades of trading experience and degrees in economics, cybersecurity, and business from Johns Hopkins, Purdue, Indiana University, and Northwestern.

Read full bio